×
Valneva SE Free Cash Flow 2021-2024 | VALN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Current Ratio
Quick Ratio
Debt/Equity Ratio
ROE
ROA
ROI
Return Tangible Eq
Valneva SE free cash flow from 2021 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Annual Chart
Annual % Change
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$204.3B
Stryker (SYK)
$148.9B
Boston Scientific (BSX)
$147.8B
EssilorLuxottica (ESLOY)
$120.4B
Medtronic (MDT)
$112.6B
Lonza Group Ag (LZAGY)
$46.2B
Haleon (HLN)
$41.7B
GE HealthCare Technologies (GEHC)
$39.9B
ResMed (RMD)
$36.3B
Terumo (TRUMY)
$28.9B
Koninklijke Philips (PHG)
$24.7B
Zimmer Biomet Holdings (ZBH)
$21.8B
Insulet (PODD)
$19.6B
Baxter (BAX)
$16.3B
Smith & Nephew SNATS (SNN)
$11B
Bio-Rad Laboratories (BIO)
$10.1B
BellRing Brands (BRBR)
$9.8B
Demant (WILYY)
$8.7B
Lantheus Holdings (LNTH)
$6.6B
ICU Medical (ICUI)
$4.1B
Prestige Consumer Healthcare (PBH)
$3.8B
Haemonetics (HAE)
$3.7B
Envista Holdings (NVST)
$3.6B
Perrigo (PRGO)
$3.3B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$3B
GN Store Nord (GNNDY)
$2.8B
Neogen (NEOG)
$2.6B
LeMaitre Vascular (LMAT)
$2.2B
AtriCure (ATRC)
$1.9B